​

SAB Biotherapeutics Ownership | Who Owns SAB Biotherapeutics?

OverviewForecastRevenueFinancialsChart

SAB Biotherapeutics Ownership Summary

SAB Biotherapeutics is owned by 23.78% institutional investors, 21.02% insiders, and 55.20% retail investors. Hb wealth management is the largest institutional shareholder, holding 0% of SABS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.50% of its assets in SAB Biotherapeutics shares.

SABS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSAB Biotherapeutics23.78%21.02%55.20%
SectorHealthcare Stocks 279.15%10.63%-189.78%
IndustryBiotech Stocks 63.94%10.67%25.38%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Hb wealth management---
Silver oak securities---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Hb wealth management---
Silver oak securities---

Top Buyers

HolderShares% AssetsChange
Silver oak securities---20.19K
Hb wealth management---263.20K

Top Sellers

HolderShares% AssetsChange
Hb wealth management---263.20K
Silver oak securities---20.19K

Sold Out

HolderChange
Silver oak securities-20.19K
Hb wealth management-263.20K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025264.00%2,209,552-15.93%232.95%1122.22%6-14.29%
Dec 31, 2024254.17%2,628,252-16.34%282.46%928.57%775.00%
Sep 30, 20242414.29%3,141,7360.47%332.97%7-4-
Jun 30, 202421-8.70%3,127,151-6.36%332.59%740.00%4-77.78%
Mar 31, 202423-37.84%3,339,666-87.53%361.77%5-66.67%18500.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv232.57K2.50%-
Vanguard Institutional Extnd Mkt Idx Tr48.67K0.52%-
Fidelity Extended Market Index43.55K0.47%-195.00
Fidelity Total Market Index12.90K0.14%-
Fidelity Series Total Market Index10.62K0.11%-
Spartan Extended Market Index Pool F8.87K0.10%93.00
NT Ext Equity Mkt Idx Fd - L8.64K0.09%-
Northern Trust Extended Eq Market Idx8.64K0.09%-
Spartan Extended Market Index Pool E8.36K0.09%356.00
Fidelity Nasdaq Composite Index4.94K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 07, 2023Sullivan Eddie Joe Chief Executive OfficerBuy$1.53K
Nov 30, 2023King Michael CHIEF FINANCIAL OFFICERBuy$4.50K
Nov 29, 2023Reich Samuel J Executive ChairmanBuy$9.84K
Sep 13, 2022HAMILTON CHRISTINE E Buy$7.30K
Sep 07, 2022Sullivan Eddie Joe CHIEF EXECUTIVE OFFICERBuy$10.32K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

SABS Ownership FAQ

Who Owns SAB Biotherapeutics?

SAB Biotherapeutics shareholders are primarily institutional investors at 23.78%, followed by 21.02% insiders and 55.20% retail investors. The average institutional ownership in SAB Biotherapeutics's industry, Biotech Stocks , is 63.94%, which SAB Biotherapeutics falls below.

Does Blackrock own SAB Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of SAB Biotherapeutics.

Who is SAB Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Hb wealth management is SAB Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 SAB Biotherapeutics shares, valued at 0$.

Who is the top mutual fund holder of SAB Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of SAB Biotherapeutics shares, with 2.50% of its total shares outstanding invested in 232.57K SAB Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools